RA Capital led the $100 million Series B round of funding for Icosavax, a startup developing vaccines based on virus-like particles. The biotech is preparing for clinical tests of vaccines for respiratory syncytial virus, human metapneumovirus, and SARS-CoV-2.
Digital primary care startup 98point6 is adding digital mental health services to its app. The company added text-based visits with a therapist or behavioral health coach to its platform.
Ozette applies artificial intelligence to immune monitoring to gain greater insight into a cancer patient’s immune system. Beyond informing treatment decisions, the technology can guide drug and diagnostic development.
Nuance Communications acquired Saykara, a startup building a medical AI voice assistant to help with charting and other administrative tasks. The deal is expected to build on Nuance’s speech recognition tools for physicians.
Nautilus, among the biotechs developing protein analysis tools for drug discovery and diagnostics, already has a partnership with Genentech. As it prepares to go public, Nautilus aims to do for proteomics what Illumina did for genomics.
Sana Biotechnology is turning new science into novel medicines intended to overcome limitations of current cell therapies. After going from stealth to IPO in two years, it’s now planning to bring multiple programs into clinical testing in 2022.
As hospitals across the country weather a surge of Covid-19 patients, in Seattle — an […]
The startup, which has seen its user base more than triple in the last year, plans to use the funds to further build out its platform.
The company has received FDA approvals for two cancer drugs in less than 12 months and announced partnerships with Merck last month for a Phase II antibody-drug conjugate and a marketed drug.